Identification of potential genomic biomarkers for Parkinson's disease using data pooling of gene expression microarrays

被引:3
|
作者
Lin, Zhijian [1 ]
Zhou, Lishu [1 ,2 ]
Li, Yaosha [1 ]
Liu, Suni [1 ]
Xie, Qizhi [1 ]
Xu, Xu [3 ]
Wu, Jun [1 ]
机构
[1] Peking Univ Shenzhen Hosp, Dept Neurol, Shenzhen 518036, Peoples R China
[2] Anhui Med Univ, Peking Univ, Clin Coll, Shenzhen Hosp, Shenzhen 518036, Peoples R China
[3] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen 518060, Peoples R China
关键词
CS; diagnostic biomarkers; Parkinson’ s disease; PRKCD; RHOG; ROC; VAMP2; weighted gene co-expression network analysis; DIAGNOSIS; PHENOTYPES; ROLES; BLOOD; AGE;
D O I
10.2217/bmm-2020-0325
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: In this study, we aimed to identify potential diagnostic biomarkers Parkinson's disease (PD) by exploring microarray gene expression data of PD patients. Materials & methods: Differentially expressed genes associated with PD were screened from the GSE99039 dataset using weighted gene co-expression network analysis, followed by gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses, gene-gene interaction network analysis and receiver operator characteristics analysis. Results: We identified two PD-associated modules, in which genes from the chemokine signaling pathway were primarily enriched. In particular, CS, PRKCD, RHOG and VAMP2 directly interacted with known PD-associated genes and showed higher expression in the PD samples, and may thus be potential biomarkers in PD diagnosis. Conclusion: A DFG-analysis identified a four-gene panel (CS, PRKCD, RHOG, VAMP2) as a potential diagnostic predictor to diagnose PD.
引用
收藏
页码:585 / 595
页数:11
相关论文
共 50 条
  • [31] Identification of candidate genes for Parkinson's disease using genetic linkage and gene expression in the substantia nigra
    Hauser, MA
    Noureddine, M
    Hulette, CM
    Yi-Ju, L
    Clemens, S
    Vance, JM
    MOVEMENT DISORDERS, 2004, 19 : S364 - S364
  • [32] Identification of colorectal cancer biomarkers using publicly available gene expression data
    LaPointe, L
    Dunne, R
    GASTROENTEROLOGY, 2005, 128 (04) : A163 - A163
  • [33] Identification of potential biomarkers of Peyronie's disease
    TomF.Lue
    Ching-ShwunLin
    Asian Journal of Andrology, 2005, (03) : 237 - 243
  • [34] Identification of potential biomarkers of Peyronie's disease
    Lin, GT
    Wang, Z
    Liu, BC
    Lue, TF
    Lin, CS
    ASIAN JOURNAL OF ANDROLOGY, 2005, 7 (03) : 237 - 243
  • [35] Identification of potential drug targets using gene expression data: A statistician's perspective.
    Gheyas, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 261 - 261
  • [36] Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease
    Denisse Sepúlveda
    Felipe Grunenwald
    Alvaro Vidal
    Paulina Troncoso-Escudero
    Marisol Cisternas-Olmedo
    Roque Villagra
    Pedro Vergara
    Carlos Aguilera
    Melissa Nassif
    Rene L. Vidal
    Scientific Reports, 12
  • [37] Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease
    Sepulveda, Denisse
    Grunenwald, Felipe
    Vidal, Alvaro
    Troncoso-Escudero, Paulina
    Cisternas-Olmedo, Marisol
    Villagra, Roque
    Vergara, Pedro
    Aguilera, Carlos
    Nassif, Melissa
    Vidal, Rene L.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [38] Data Analysis in Neural Gene Expression Profiling using Microarrays
    不详
    NEUROFORUM, 2009, 15 (02): : 65 - 65
  • [39] Identifying potential gene biomarkers for Parkinson's disease through an information entropy based approach
    Monaco, A.
    Pantaleo, E.
    Amoroso, N.
    Bellantuono, L.
    Lombardi, A.
    Tateo, A.
    Tangaro, S.
    Bellotti, R.
    PHYSICAL BIOLOGY, 2020, 18 (01)
  • [40] Gene expression in the Parkinson's disease brain
    Lewis, Patrick A.
    Cookson, Mark R.
    BRAIN RESEARCH BULLETIN, 2012, 88 (04) : 302 - 312